Global Chronic Cough Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Chronic Cough market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Chronic cough isdefined as a persistent cough that lasts long up to 6-8 weeks. It significantlyaffects the life of the patients by interrupting sleep, creating vomitingsensation, light-headedness, and even rib fractures. It is caused due tomultiple reasons such as infections, asthma, and gastro esophageal refluxdisease (GERD).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Chronic Cough industry chain, the market status of HospitalPharmacy (Oral, Injections), OnlinePharmacy (Oral, Injections), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Chronic Cough.

Regionally, the report analyzes the Chronic Cough markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Chronic Cough market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Chronic Cough market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Chronic Cough industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oral, Injections).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Chronic Cough market.

Regional Analysis: The report involves examining the Chronic Cough market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Chronic Cough market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Chronic Cough:
Company Analysis: Report covers individual Chronic Cough players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Chronic Cough This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (HospitalPharmacy, OnlinePharmacy).

Technology Analysis: Report covers specific technologies relevant to Chronic Cough. It assesses the current state, advancements, and potential future developments in Chronic Cough areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Chronic Cough market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Chronic Cough market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Oral
    Injections
    Nasal
    Others

Market segment by Application
    HospitalPharmacy
    OnlinePharmacy
    RetailPharmacy

Market segment by players, this report covers
    Novartis AG
    Teva Pharmaceutical Industries Ltd
    GlaxoSmithKline
    Bayer AG
    Mylan N.V.
    Amneal Pharmaceuticals, Inc.
    Cipla Inc.
    Reckitt Benckiser Group
    Sun Pharmaceutical Industries Ltd
    Aurobindo Pharma Ltd

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Chronic Cough product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Chronic Cough, with revenue, gross margin and global market share of Chronic Cough from 2019 to 2024.
Chapter 3, the Chronic Cough competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Chronic Cough market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Chronic Cough.
Chapter 13, to describe Chronic Cough research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Chronic Cough
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Chronic Cough by Type
        1.3.1 Overview: Global Chronic Cough Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Chronic Cough Consumption Value Market Share by Type in 2023
        1.3.3 Oral
        1.3.4 Injections
        1.3.5 Nasal
        1.3.6 Others
    1.4 Global Chronic Cough Market by Application
        1.4.1 Overview: Global Chronic Cough Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 HospitalPharmacy
        1.4.3 OnlinePharmacy
        1.4.4 RetailPharmacy
    1.5 Global Chronic Cough Market Size & Forecast
    1.6 Global Chronic Cough Market Size and Forecast by Region
        1.6.1 Global Chronic Cough Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Chronic Cough Market Size by Region, (2019-2030)
        1.6.3 North America Chronic Cough Market Size and Prospect (2019-2030)
        1.6.4 Europe Chronic Cough Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Chronic Cough Market Size and Prospect (2019-2030)
        1.6.6 South America Chronic Cough Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Chronic Cough Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Novartis AG
        2.1.1 Novartis AG Details
        2.1.2 Novartis AG Major Business
        2.1.3 Novartis AG Chronic Cough Product and Solutions
        2.1.4 Novartis AG Chronic Cough Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Novartis AG Recent Developments and Future Plans
    2.2 Teva Pharmaceutical Industries Ltd
        2.2.1 Teva Pharmaceutical Industries Ltd Details
        2.2.2 Teva Pharmaceutical Industries Ltd Major Business
        2.2.3 Teva Pharmaceutical Industries Ltd Chronic Cough Product and Solutions
        2.2.4 Teva Pharmaceutical Industries Ltd Chronic Cough Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Teva Pharmaceutical Industries Ltd Recent Developments and Future Plans
    2.3 GlaxoSmithKline
        2.3.1 GlaxoSmithKline Details
        2.3.2 GlaxoSmithKline Major Business
        2.3.3 GlaxoSmithKline Chronic Cough Product and Solutions
        2.3.4 GlaxoSmithKline Chronic Cough Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 GlaxoSmithKline Recent Developments and Future Plans
    2.4 Bayer AG
        2.4.1 Bayer AG Details
        2.4.2 Bayer AG Major Business
        2.4.3 Bayer AG Chronic Cough Product and Solutions
        2.4.4 Bayer AG Chronic Cough Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Bayer AG Recent Developments and Future Plans
    2.5 Mylan N.V.
        2.5.1 Mylan N.V. Details
        2.5.2 Mylan N.V. Major Business
        2.5.3 Mylan N.V. Chronic Cough Product and Solutions
        2.5.4 Mylan N.V. Chronic Cough Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Mylan N.V. Recent Developments and Future Plans
    2.6 Amneal Pharmaceuticals, Inc.
        2.6.1 Amneal Pharmaceuticals, Inc. Details
        2.6.2 Amneal Pharmaceuticals, Inc. Major Business
        2.6.3 Amneal Pharmaceuticals, Inc. Chronic Cough Product and Solutions
        2.6.4 Amneal Pharmaceuticals, Inc. Chronic Cough Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Amneal Pharmaceuticals, Inc. Recent Developments and Future Plans
    2.7 Cipla Inc.
        2.7.1 Cipla Inc. Details
        2.7.2 Cipla Inc. Major Business
        2.7.3 Cipla Inc. Chronic Cough Product and Solutions
        2.7.4 Cipla Inc. Chronic Cough Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Cipla Inc. Recent Developments and Future Plans
    2.8 Reckitt Benckiser Group
        2.8.1 Reckitt Benckiser Group Details
        2.8.2 Reckitt Benckiser Group Major Business
        2.8.3 Reckitt Benckiser Group Chronic Cough Product and Solutions
        2.8.4 Reckitt Benckiser Group Chronic Cough Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Reckitt Benckiser Group Recent Developments and Future Plans
    2.9 Sun Pharmaceutical Industries Ltd
        2.9.1 Sun Pharmaceutical Industries Ltd Details
        2.9.2 Sun Pharmaceutical Industries Ltd Major Business
        2.9.3 Sun Pharmaceutical Industries Ltd Chronic Cough Product and Solutions
        2.9.4 Sun Pharmaceutical Industries Ltd Chronic Cough Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
    2.10 Aurobindo Pharma Ltd
        2.10.1 Aurobindo Pharma Ltd Details
        2.10.2 Aurobindo Pharma Ltd Major Business
        2.10.3 Aurobindo Pharma Ltd Chronic Cough Product and Solutions
        2.10.4 Aurobindo Pharma Ltd Chronic Cough Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Aurobindo Pharma Ltd Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Chronic Cough Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Chronic Cough by Company Revenue
        3.2.2 Top 3 Chronic Cough Players Market Share in 2023
        3.2.3 Top 6 Chronic Cough Players Market Share in 2023
    3.3 Chronic Cough Market: Overall Company Footprint Analysis
        3.3.1 Chronic Cough Market: Region Footprint
        3.3.2 Chronic Cough Market: Company Product Type Footprint
        3.3.3 Chronic Cough Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Chronic Cough Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Chronic Cough Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Chronic Cough Consumption Value Market Share by Application (2019-2024)
    5.2 Global Chronic Cough Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Chronic Cough Consumption Value by Type (2019-2030)
    6.2 North America Chronic Cough Consumption Value by Application (2019-2030)
    6.3 North America Chronic Cough Market Size by Country
        6.3.1 North America Chronic Cough Consumption Value by Country (2019-2030)
        6.3.2 United States Chronic Cough Market Size and Forecast (2019-2030)
        6.3.3 Canada Chronic Cough Market Size and Forecast (2019-2030)
        6.3.4 Mexico Chronic Cough Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Chronic Cough Consumption Value by Type (2019-2030)
    7.2 Europe Chronic Cough Consumption Value by Application (2019-2030)
    7.3 Europe Chronic Cough Market Size by Country
        7.3.1 Europe Chronic Cough Consumption Value by Country (2019-2030)
        7.3.2 Germany Chronic Cough Market Size and Forecast (2019-2030)
        7.3.3 France Chronic Cough Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Chronic Cough Market Size and Forecast (2019-2030)
        7.3.5 Russia Chronic Cough Market Size and Forecast (2019-2030)
        7.3.6 Italy Chronic Cough Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Chronic Cough Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Chronic Cough Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Chronic Cough Market Size by Region
        8.3.1 Asia-Pacific Chronic Cough Consumption Value by Region (2019-2030)
        8.3.2 China Chronic Cough Market Size and Forecast (2019-2030)
        8.3.3 Japan Chronic Cough Market Size and Forecast (2019-2030)
        8.3.4 South Korea Chronic Cough Market Size and Forecast (2019-2030)
        8.3.5 India Chronic Cough Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Chronic Cough Market Size and Forecast (2019-2030)
        8.3.7 Australia Chronic Cough Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Chronic Cough Consumption Value by Type (2019-2030)
    9.2 South America Chronic Cough Consumption Value by Application (2019-2030)
    9.3 South America Chronic Cough Market Size by Country
        9.3.1 South America Chronic Cough Consumption Value by Country (2019-2030)
        9.3.2 Brazil Chronic Cough Market Size and Forecast (2019-2030)
        9.3.3 Argentina Chronic Cough Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Chronic Cough Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Chronic Cough Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Chronic Cough Market Size by Country
        10.3.1 Middle East & Africa Chronic Cough Consumption Value by Country (2019-2030)
        10.3.2 Turkey Chronic Cough Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Chronic Cough Market Size and Forecast (2019-2030)
        10.3.4 UAE Chronic Cough Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Chronic Cough Market Drivers
    11.2 Chronic Cough Market Restraints
    11.3 Chronic Cough Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Chronic Cough Industry Chain
    12.2 Chronic Cough Upstream Analysis
    12.3 Chronic Cough Midstream Analysis
    12.4 Chronic Cough Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Chronic Cough Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Chronic Cough Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Chronic Cough Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Chronic Cough Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Novartis AG Company Information, Head Office, and Major Competitors
    Table 6. Novartis AG Major Business
    Table 7. Novartis AG Chronic Cough Product and Solutions
    Table 8. Novartis AG Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Novartis AG Recent Developments and Future Plans
    Table 10. Teva Pharmaceutical Industries Ltd Company Information, Head Office, and Major Competitors
    Table 11. Teva Pharmaceutical Industries Ltd Major Business
    Table 12. Teva Pharmaceutical Industries Ltd Chronic Cough Product and Solutions
    Table 13. Teva Pharmaceutical Industries Ltd Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Teva Pharmaceutical Industries Ltd Recent Developments and Future Plans
    Table 15. GlaxoSmithKline Company Information, Head Office, and Major Competitors
    Table 16. GlaxoSmithKline Major Business
    Table 17. GlaxoSmithKline Chronic Cough Product and Solutions
    Table 18. GlaxoSmithKline Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. GlaxoSmithKline Recent Developments and Future Plans
    Table 20. Bayer AG Company Information, Head Office, and Major Competitors
    Table 21. Bayer AG Major Business
    Table 22. Bayer AG Chronic Cough Product and Solutions
    Table 23. Bayer AG Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Bayer AG Recent Developments and Future Plans
    Table 25. Mylan N.V. Company Information, Head Office, and Major Competitors
    Table 26. Mylan N.V. Major Business
    Table 27. Mylan N.V. Chronic Cough Product and Solutions
    Table 28. Mylan N.V. Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Mylan N.V. Recent Developments and Future Plans
    Table 30. Amneal Pharmaceuticals, Inc. Company Information, Head Office, and Major Competitors
    Table 31. Amneal Pharmaceuticals, Inc. Major Business
    Table 32. Amneal Pharmaceuticals, Inc. Chronic Cough Product and Solutions
    Table 33. Amneal Pharmaceuticals, Inc. Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Amneal Pharmaceuticals, Inc. Recent Developments and Future Plans
    Table 35. Cipla Inc. Company Information, Head Office, and Major Competitors
    Table 36. Cipla Inc. Major Business
    Table 37. Cipla Inc. Chronic Cough Product and Solutions
    Table 38. Cipla Inc. Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Cipla Inc. Recent Developments and Future Plans
    Table 40. Reckitt Benckiser Group Company Information, Head Office, and Major Competitors
    Table 41. Reckitt Benckiser Group Major Business
    Table 42. Reckitt Benckiser Group Chronic Cough Product and Solutions
    Table 43. Reckitt Benckiser Group Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Reckitt Benckiser Group Recent Developments and Future Plans
    Table 45. Sun Pharmaceutical Industries Ltd Company Information, Head Office, and Major Competitors
    Table 46. Sun Pharmaceutical Industries Ltd Major Business
    Table 47. Sun Pharmaceutical Industries Ltd Chronic Cough Product and Solutions
    Table 48. Sun Pharmaceutical Industries Ltd Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
    Table 50. Aurobindo Pharma Ltd Company Information, Head Office, and Major Competitors
    Table 51. Aurobindo Pharma Ltd Major Business
    Table 52. Aurobindo Pharma Ltd Chronic Cough Product and Solutions
    Table 53. Aurobindo Pharma Ltd Chronic Cough Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Aurobindo Pharma Ltd Recent Developments and Future Plans
    Table 55. Global Chronic Cough Revenue (USD Million) by Players (2019-2024)
    Table 56. Global Chronic Cough Revenue Share by Players (2019-2024)
    Table 57. Breakdown of Chronic Cough by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in Chronic Cough, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 59. Head Office of Key Chronic Cough Players
    Table 60. Chronic Cough Market: Company Product Type Footprint
    Table 61. Chronic Cough Market: Company Product Application Footprint
    Table 62. Chronic Cough New Market Entrants and Barriers to Market Entry
    Table 63. Chronic Cough Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global Chronic Cough Consumption Value (USD Million) by Type (2019-2024)
    Table 65. Global Chronic Cough Consumption Value Share by Type (2019-2024)
    Table 66. Global Chronic Cough Consumption Value Forecast by Type (2025-2030)
    Table 67. Global Chronic Cough Consumption Value by Application (2019-2024)
    Table 68. Global Chronic Cough Consumption Value Forecast by Application (2025-2030)
    Table 69. North America Chronic Cough Consumption Value by Type (2019-2024) & (USD Million)
    Table 70. North America Chronic Cough Consumption Value by Type (2025-2030) & (USD Million)
    Table 71. North America Chronic Cough Consumption Value by Application (2019-2024) & (USD Million)
    Table 72. North America Chronic Cough Consumption Value by Application (2025-2030) & (USD Million)
    Table 73. North America Chronic Cough Consumption Value by Country (2019-2024) & (USD Million)
    Table 74. North America Chronic Cough Consumption Value by Country (2025-2030) & (USD Million)
    Table 75. Europe Chronic Cough Consumption Value by Type (2019-2024) & (USD Million)
    Table 76. Europe Chronic Cough Consumption Value by Type (2025-2030) & (USD Million)
    Table 77. Europe Chronic Cough Consumption Value by Application (2019-2024) & (USD Million)
    Table 78. Europe Chronic Cough Consumption Value by Application (2025-2030) & (USD Million)
    Table 79. Europe Chronic Cough Consumption Value by Country (2019-2024) & (USD Million)
    Table 80. Europe Chronic Cough Consumption Value by Country (2025-2030) & (USD Million)
    Table 81. Asia-Pacific Chronic Cough Consumption Value by Type (2019-2024) & (USD Million)
    Table 82. Asia-Pacific Chronic Cough Consumption Value by Type (2025-2030) & (USD Million)
    Table 83. Asia-Pacific Chronic Cough Consumption Value by Application (2019-2024) & (USD Million)
    Table 84. Asia-Pacific Chronic Cough Consumption Value by Application (2025-2030) & (USD Million)
    Table 85. Asia-Pacific Chronic Cough Consumption Value by Region (2019-2024) & (USD Million)
    Table 86. Asia-Pacific Chronic Cough Consumption Value by Region (2025-2030) & (USD Million)
    Table 87. South America Chronic Cough Consumption Value by Type (2019-2024) & (USD Million)
    Table 88. South America Chronic Cough Consumption Value by Type (2025-2030) & (USD Million)
    Table 89. South America Chronic Cough Consumption Value by Application (2019-2024) & (USD Million)
    Table 90. South America Chronic Cough Consumption Value by Application (2025-2030) & (USD Million)
    Table 91. South America Chronic Cough Consumption Value by Country (2019-2024) & (USD Million)
    Table 92. South America Chronic Cough Consumption Value by Country (2025-2030) & (USD Million)
    Table 93. Middle East & Africa Chronic Cough Consumption Value by Type (2019-2024) & (USD Million)
    Table 94. Middle East & Africa Chronic Cough Consumption Value by Type (2025-2030) & (USD Million)
    Table 95. Middle East & Africa Chronic Cough Consumption Value by Application (2019-2024) & (USD Million)
    Table 96. Middle East & Africa Chronic Cough Consumption Value by Application (2025-2030) & (USD Million)
    Table 97. Middle East & Africa Chronic Cough Consumption Value by Country (2019-2024) & (USD Million)
    Table 98. Middle East & Africa Chronic Cough Consumption Value by Country (2025-2030) & (USD Million)
    Table 99. Chronic Cough Raw Material
    Table 100. Key Suppliers of Chronic Cough Raw Materials
List of Figures
    Figure 1. Chronic Cough Picture
    Figure 2. Global Chronic Cough Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Chronic Cough Consumption Value Market Share by Type in 2023
    Figure 4. Oral
    Figure 5. Injections
    Figure 6. Nasal
    Figure 7. Others
    Figure 8. Global Chronic Cough Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 9. Chronic Cough Consumption Value Market Share by Application in 2023
    Figure 10. HospitalPharmacy Picture
    Figure 11. OnlinePharmacy Picture
    Figure 12. RetailPharmacy Picture
    Figure 13. Global Chronic Cough Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Chronic Cough Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Market Chronic Cough Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 16. Global Chronic Cough Consumption Value Market Share by Region (2019-2030)
    Figure 17. Global Chronic Cough Consumption Value Market Share by Region in 2023
    Figure 18. North America Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 20. Asia-Pacific Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 21. South America Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 22. Middle East and Africa Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 23. Global Chronic Cough Revenue Share by Players in 2023
    Figure 24. Chronic Cough Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 25. Global Top 3 Players Chronic Cough Market Share in 2023
    Figure 26. Global Top 6 Players Chronic Cough Market Share in 2023
    Figure 27. Global Chronic Cough Consumption Value Share by Type (2019-2024)
    Figure 28. Global Chronic Cough Market Share Forecast by Type (2025-2030)
    Figure 29. Global Chronic Cough Consumption Value Share by Application (2019-2024)
    Figure 30. Global Chronic Cough Market Share Forecast by Application (2025-2030)
    Figure 31. North America Chronic Cough Consumption Value Market Share by Type (2019-2030)
    Figure 32. North America Chronic Cough Consumption Value Market Share by Application (2019-2030)
    Figure 33. North America Chronic Cough Consumption Value Market Share by Country (2019-2030)
    Figure 34. United States Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 35. Canada Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 36. Mexico Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 37. Europe Chronic Cough Consumption Value Market Share by Type (2019-2030)
    Figure 38. Europe Chronic Cough Consumption Value Market Share by Application (2019-2030)
    Figure 39. Europe Chronic Cough Consumption Value Market Share by Country (2019-2030)
    Figure 40. Germany Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 41. France Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 42. United Kingdom Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 43. Russia Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 44. Italy Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 45. Asia-Pacific Chronic Cough Consumption Value Market Share by Type (2019-2030)
    Figure 46. Asia-Pacific Chronic Cough Consumption Value Market Share by Application (2019-2030)
    Figure 47. Asia-Pacific Chronic Cough Consumption Value Market Share by Region (2019-2030)
    Figure 48. China Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 49. Japan Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 50. South Korea Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 51. India Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 52. Southeast Asia Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 53. Australia Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 54. South America Chronic Cough Consumption Value Market Share by Type (2019-2030)
    Figure 55. South America Chronic Cough Consumption Value Market Share by Application (2019-2030)
    Figure 56. South America Chronic Cough Consumption Value Market Share by Country (2019-2030)
    Figure 57. Brazil Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 58. Argentina Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 59. Middle East and Africa Chronic Cough Consumption Value Market Share by Type (2019-2030)
    Figure 60. Middle East and Africa Chronic Cough Consumption Value Market Share by Application (2019-2030)
    Figure 61. Middle East and Africa Chronic Cough Consumption Value Market Share by Country (2019-2030)
    Figure 62. Turkey Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 63. Saudi Arabia Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 64. UAE Chronic Cough Consumption Value (2019-2030) & (USD Million)
    Figure 65. Chronic Cough Market Drivers
    Figure 66. Chronic Cough Market Restraints
    Figure 67. Chronic Cough Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Chronic Cough in 2023
    Figure 70. Manufacturing Process Analysis of Chronic Cough
    Figure 71. Chronic Cough Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Companies Mentioned

Novartis AG
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline
Bayer AG
Mylan N.V.
Amneal Pharmaceuticals, Inc.
Cipla Inc.
Reckitt Benckiser Group
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma Ltd